ArticleFrontiers in neurology
Development and validation of a nomogram for predicting recurrence in patients with Meige syndrome after radiofrequency ablation.
Article in Frontiers in neurology. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Not yet cited in PubMed.
What it found
Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.
The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.
The trial behind it
Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.
Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.
Who cites it
0 citing papers in PubMed.
No citing paper in PubMed yet.
Corrections and comments
PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.
Authors and funding
3 authors.
Funding
No grant is acknowledged in the PubMed record.
Abstract
Introduction: Radiofrequency ablation targeting the extracranial facial nerve has emerged as an effective therapeutic option for patients with Meige syndrome (MS) presenting predominantly with blepharospasm. However, postoperative recurrence remains a major clinical challenge. This study aimed to develop and internally validate a nomogram for predicting 1-year recurrence after CT-guided facial nerve radiofrequency ablation via bilateral stylomastoid foramen. Methods: This study retrospectively analyzed 119 patients with MS who underwent CT-guided facial nerve radiofrequency ablation via bilateral stylomastoid foramen at the Pain Department of Jiaxing University Affiliated Hospital between November 2021 and December 2024. The Lasso regression and multivariate logistic regression analysis were employed to identify independent factors associated with postoperative recurrence. A nomogram was constructed based on these factors and internally validated using the bootstrap resampling method. Results: Our analysis indicates that independent factors influencing recurrence are the Jankovic Rating score (JRS),disease duration, and final temperature. A nomogram was constructed based on these predictors. The area under the ROC curve (AUC) for the nomogram was 0.932 (95% CI: 0.912-0.958). Calibration curves demonstrated excellent agreement between predicted probabilities and actual observed values. Decision curve analysis (DCA) indicated that the nomogram predictive model had a higher net benefit for predicting the risk of postoperative recurrence in MS patients. Conclusion: This study constructed a static and dynamic online nomogram with excellent differentiation, calibration, and accuracy, aiding in the identification of high-risk postoperative patients and assisting physicians in decision-making.
Indexed as
Identifiers
What OpenQuestion holds
Registered trials
Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.